# Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants

> **NCT06708520** · PHASE1 · RECRUITING · sponsor: **Noucor Health S.A.** · enrollment: 48 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Rupatadine

## Key facts

- **NCT ID:** NCT06708520
- **Lead sponsor:** Noucor Health S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-21
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06708520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06708520, "Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06708520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*